⌘K

Login Start Free

Home/Filings/4/0001790340-25-000117

4//SEC Filing

Feinberg Peter 4

Accession 0001790340-25-000117

CIK 0001790340other

View on SEC.gov Company Profile

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 9:00 AM ET

Size

6.8 KB

Accession

0001790340-25-000117

Insider Transaction Report

Form 4

Period: 2025-09-29

Immuneering CorpIMRX

Director

Transactions

Purchase
Class A Common Stock
2025-09-29$7.18/sh+5,000$35,900→ 141,766 total

Holdings

Class A Common Stock
(indirect: General Partner of PF Associates L.P.)
392,242
Class A Common Stock
(indirect: By LLC)
115,441
Class A Common Stock
(indirect: By LLC)
476,615

Documents

1 file

4
wk-form4_1759237255.xmlPrimary
FORM 4

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1

filerCIK 0001870076

Filing Metadata

Form type: 4
Filed: Sep 29, 8:00 PM ET
Accepted: Sep 30, 9:00 AM ET
Size: 6.8 KB

View on SEC.gov